vs

Side-by-side financial comparison of Linde plc (LIN) and Lam Research (LRCX). Click either name above to swap in a different company.

Lam Research is the larger business by last-quarter revenue ($5.8B vs $8.8M, roughly 665.2× Linde plc). On growth, Lam Research posted the faster year-over-year revenue change (23.8% vs 8.2%). Over the past eight quarters, Lam Research's revenue compounded faster (22.8% CAGR vs -96.7%).

Linde is a global multinational chemical company and the world's largest industrial gas supplier by market share and revenue. Founded by German scientist and engineer Carl von Linde in 1879 in Wiesbaden, Germany, the company is now headquartered in Woking, United Kingdom, and registered in Ireland as Linde plc. Linde plc was formed in 2018 through the merger of Linde AG and Praxair, which was founded in 1907 in the United States as Linde Air Products Company.

Lam Research Corporation is an American supplier of wafer-fabrication equipment and related services to the semiconductor industry. Its products are used primarily in front-end wafer processing, which involves the steps that create the active components of semiconductor devices and their wiring (interconnects). The company also builds equipment for back-end wafer-level packaging (WLP) and for related manufacturing markets such as for microelectromechanical systems (MEMS).

LIN vs LRCX — Head-to-Head

Bigger by revenue
LRCX
LRCX
665.2× larger
LRCX
$5.8B
$8.8M
LIN
Growing faster (revenue YoY)
LRCX
LRCX
+15.5% gap
LRCX
23.8%
8.2%
LIN
Faster 2-yr revenue CAGR
LRCX
LRCX
Annualised
LRCX
22.8%
-96.7%
LIN

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
LIN
LIN
LRCX
LRCX
Revenue
$8.8M
$5.8B
Net Profit
$1.8B
Gross Margin
48.5%
49.8%
Operating Margin
27.8%
35.0%
Net Margin
31.2%
Revenue YoY
8.2%
23.8%
Net Profit YoY
37.2%
EPS (diluted)
$3.98
$1.45

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LIN
LIN
LRCX
LRCX
Q1 26
$8.8M
$5.8B
Q4 25
$8.8B
$5.3B
Q3 25
$8.6B
$5.3B
Q2 25
$8.5B
$5.2B
Q1 25
$8.1B
$4.7B
Q4 24
$8.3B
$4.4B
Q3 24
$8.4B
$4.2B
Q2 24
$8.3B
$3.9B
Net Profit
LIN
LIN
LRCX
LRCX
Q1 26
$1.8B
Q4 25
$1.5B
$1.6B
Q3 25
$1.9B
$1.6B
Q2 25
$1.8B
$1.7B
Q1 25
$1.7B
$1.3B
Q4 24
$1.7B
$1.2B
Q3 24
$1.6B
$1.1B
Q2 24
$1.7B
$1.0B
Gross Margin
LIN
LIN
LRCX
LRCX
Q1 26
48.5%
49.8%
Q4 25
49.6%
Q3 25
50.4%
Q2 25
50.1%
Q1 25
49.0%
Q4 24
47.4%
Q3 24
48.0%
Q2 24
47.5%
Operating Margin
LIN
LIN
LRCX
LRCX
Q1 26
27.8%
35.0%
Q4 25
23.0%
33.9%
Q3 25
27.5%
34.4%
Q2 25
27.7%
33.7%
Q1 25
26.9%
33.1%
Q4 24
27.4%
30.5%
Q3 24
25.0%
30.3%
Q2 24
26.4%
29.1%
Net Margin
LIN
LIN
LRCX
LRCX
Q1 26
31.2%
Q4 25
17.5%
29.8%
Q3 25
22.4%
29.5%
Q2 25
20.8%
33.3%
Q1 25
20.6%
28.2%
Q4 24
20.8%
27.2%
Q3 24
18.5%
26.8%
Q2 24
20.1%
26.4%
EPS (diluted)
LIN
LIN
LRCX
LRCX
Q1 26
$3.98
$1.45
Q4 25
$3.28
$1.26
Q3 25
$4.09
$1.24
Q2 25
$3.73
$1.34
Q1 25
$3.51
$1.03
Q4 24
$3.61
$0.92
Q3 24
$3.22
$0.86
Q2 24
$3.44
$7.78

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LIN
LIN
LRCX
LRCX
Cash + ST InvestmentsLiquidity on hand
$4.0M
$4.8B
Total DebtLower is stronger
$24.7M
Stockholders' EquityBook value
$40.1M
Total Assets
$86.3M
$20.8B
Debt / EquityLower = less leverage
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LIN
LIN
LRCX
LRCX
Q1 26
$4.0M
$4.8B
Q4 25
$5.1B
$6.2B
Q3 25
$4.5B
$6.7B
Q2 25
$4.8B
$6.4B
Q1 25
$5.3B
$5.5B
Q4 24
$4.8B
$5.7B
Q3 24
$5.2B
$6.1B
Q2 24
$4.6B
$5.8B
Total Debt
LIN
LIN
LRCX
LRCX
Q1 26
$24.7M
Q4 25
$20.7B
$3.7B
Q3 25
$18.6B
$3.7B
Q2 25
$19.7B
$3.7B
Q1 25
$17.6B
$3.7B
Q4 24
$15.3B
$4.5B
Q3 24
$17.5B
$4.5B
Q2 24
$16.9B
$4.5B
Stockholders' Equity
LIN
LIN
LRCX
LRCX
Q1 26
$40.1M
Q4 25
$38.2B
$10.1B
Q3 25
$38.6B
$10.2B
Q2 25
$38.5B
$9.9B
Q1 25
$38.0B
$9.5B
Q4 24
$38.1B
$8.8B
Q3 24
$39.2B
$8.5B
Q2 24
$38.2B
$8.5B
Total Assets
LIN
LIN
LRCX
LRCX
Q1 26
$86.3M
$20.8B
Q4 25
$86.8B
$21.4B
Q3 25
$86.0B
$21.9B
Q2 25
$86.1B
$21.3B
Q1 25
$82.7B
$20.0B
Q4 24
$80.1B
$19.8B
Q3 24
$82.5B
$19.5B
Q2 24
$80.2B
$18.7B
Debt / Equity
LIN
LIN
LRCX
LRCX
Q1 26
0.62×
Q4 25
0.54×
0.37×
Q3 25
0.48×
0.37×
Q2 25
0.51×
0.38×
Q1 25
0.46×
0.39×
Q4 24
0.40×
0.51×
Q3 24
0.45×
0.53×
Q2 24
0.44×
0.52×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LIN
LIN
LRCX
LRCX
Operating Cash FlowLast quarter
$1.1B
Free Cash FlowOCF − Capex
$898.0K
FCF MarginFCF / Revenue
10.2%
Capex IntensityCapex / Revenue
5.7%
Cash ConversionOCF / Net Profit
0.63×
TTM Free Cash FlowTrailing 4 quarters
$4.2B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LIN
LIN
LRCX
LRCX
Q1 26
$1.1B
Q4 25
$3.0B
$1.5B
Q3 25
$2.9B
$1.8B
Q2 25
$2.2B
$2.6B
Q1 25
$2.2B
$1.3B
Q4 24
$2.8B
$741.9M
Q3 24
$2.7B
$1.6B
Q2 24
$1.9B
$862.4M
Free Cash Flow
LIN
LIN
LRCX
LRCX
Q1 26
$898.0K
Q4 25
$1.6B
$1.2B
Q3 25
$1.7B
$1.6B
Q2 25
$954.0M
$2.4B
Q1 25
$891.0M
$1.0B
Q4 24
$1.6B
$553.6M
Q3 24
$1.7B
$1.5B
Q2 24
$796.0M
$761.7M
FCF Margin
LIN
LIN
LRCX
LRCX
Q1 26
10.2%
Q4 25
17.9%
22.8%
Q3 25
19.4%
29.9%
Q2 25
11.2%
46.1%
Q1 25
11.0%
21.6%
Q4 24
18.8%
12.7%
Q3 24
19.9%
35.0%
Q2 24
9.6%
19.7%
Capex Intensity
LIN
LIN
LRCX
LRCX
Q1 26
5.7%
Q4 25
16.6%
4.9%
Q3 25
14.8%
3.5%
Q2 25
14.8%
3.3%
Q1 25
15.7%
6.1%
Q4 24
15.1%
4.3%
Q3 24
12.8%
2.7%
Q2 24
13.7%
2.6%
Cash Conversion
LIN
LIN
LRCX
LRCX
Q1 26
0.63×
Q4 25
1.98×
0.93×
Q3 25
1.53×
1.13×
Q2 25
1.25×
1.48×
Q1 25
1.29×
0.98×
Q4 24
1.63×
0.62×
Q3 24
1.76×
1.40×
Q2 24
1.16×
0.85×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons